source Post navigation Novo Nordisk's Rybelsus Sets New Standard: 14% Cut in Cardiovascular Risks for Diabetics – Yahoo Finance Manufacturer confirms discontinuation of type 2 diabetes mellitus treatment Victoza – The Pharmaceutical Journal